Antiparkinsonian medication and pathological gambling.

CNS Drugs
Malcolm Lader

Abstract

Parkinson's disease is a common condition, usually treated by dopaminergic agents, both ergot and non-ergot. Many behavioural abnormalities are associated with such usage, including impulse control disorders (ICDs), dopamine dysregulation syndrome and 'punding'. Pathological gambling, a form of ICD, comprises persistent and maladaptive gambling of various types that disrupts personal, family or occupational activity. Pathological gambling may be associated with other abnormal actions such as pathological shopping, hoarding and hypersexuality. The incidence varies widely from study to study but may be up to 7% of users of dopaminergic agents. Recognition of this problem has led drug regulatory agencies to add precautions concerning pathological gambling to official drug information for the entire class of antiparkinsonian medications. The literature is not entirely consistent and opinions differ greatly, but pramipexole (a dopamine D2 and D3 agonist), and perhaps ropinirole (also a D2/D3 agonist), may be especially likely to be associated with pathological gambling, although the precise nature of the relationship is unclear. Treatment involves reducing the dose of the medication or switching to another medication; unfortunately,...Continue Reading

References

Sep 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·P A Kettl, I M Marks
Apr 27, 1999·Nature·T W Robbins, B J Everitt
Mar 23, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·G GiovannoniA J Lees
Mar 29, 2000·Brain : a Journal of Neurology·G FénelonM Ziégler
Jun 30, 2000·The American Journal of Psychiatry·G W HallD A Gorelick
Sep 29, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·J A MolinaF Bermejo
Feb 24, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·R Cantello
Jun 8, 2001·Clinical Neuropharmacology·U GschwandtnerP Fuhr
Oct 18, 2002·Neuron·Wolfram Schultz
Mar 14, 2003·Archives of Neurology·Dag AarslandPer Kragh-Sørensen
Mar 15, 2003·Journal of Gambling Studies·Angela IbáñezJeronimo Sáiz-Ruiz
Mar 22, 2003·Science·Peter Shizgal, Andreas Arvanitogiannis
Mar 22, 2003·Science·Christopher D FiorilloWolfram Schultz
Aug 13, 2003·Archives of General Psychiatry·Marc N PotenzaBruce E Wexler
Apr 13, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Roger Kurlan
Jun 29, 2004·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·M AvanziF Bonfà
Jul 13, 2004·Current Opinion in Neurology·Andrew H Evans, Andrew J Lees
Aug 18, 2004·Journal of Geriatric Psychiatry and Neurology·David J Burn, Alexander I Tröster
Jan 12, 2005·Nature Neuroscience·Jan ReuterChristian Büchel
Mar 25, 2005·CNS Spectrums·Dan J Stein, Jon E Grant
Jul 13, 2005·Archives of Neurology·M Leann DoddJ Eric Ahlskog
Sep 20, 2005·Lancet Neurology·Fabrizio Stocchi
Nov 2, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Melissa J Nirenberg, Cheryl Waters
Feb 16, 2006·Archives of Neurology·John C MorganKapil D Sethi
Feb 16, 2006·Archives of Neurology·Cathy LuOksana Suchowersky
Feb 21, 2006·Lancet Neurology·K Ray ChaudhuriUNKNOWN National Institute for Clinical Excellence
May 30, 2006·Parkinsonism & Related Disorders·Michael A ShapiroHubert H Fernandez
Jun 24, 2006·Thérapie·Jean-Louis MontastrucOlivier Rascol
Aug 9, 2006·Expert Review of Neurotherapeutics·Alan Diamond, Joseph Jankovic
Sep 15, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Claire ArdouinPaul Krack
Oct 3, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Katherine A GrossetD G Grosset
Oct 3, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Laura Silveira-MoriyamaAndrew J Lees
Oct 18, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Maurizio AvanziFlavio Bonfà
Oct 31, 2006·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Helge FrielingStefan Bleich
Feb 14, 2007·Archives of Neurology·Valerie VoonMateusz Zurowski
Apr 21, 2007·BMJ : British Medical Journal·Sui H Wong, Malcolm J Steiger

❮ Previous
Next ❯

Citations

Sep 4, 2010·Psychopharmacology·Patrick S JohnsonStephen C Fowler
Dec 1, 2012·International Psychogeriatrics·Tomoyuki NagataKazuhiko Nakayama
Jan 5, 2013·Behavioural and Cognitive Psychotherapy·Francesco BulliRandy O Frost
Jun 16, 2010·Experimental and Clinical Psychopharmacology·Gregory J MaddenStephen C Fowler
Feb 1, 2012·Experimental and Clinical Psychopharmacology·Patrick S JohnsonJeffrey S Stein
Jan 11, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Colin M StopperStan B Floresco
Jul 26, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Katherine E BurdickAnil K Malhotra
Jan 21, 2009·Brain : a Journal of Neurology·Isabelle BoileauStephen J Kish
Jan 18, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Daniel S McGrathPauwlina R McGrath
May 1, 2013·Journal of Addiction Medicine·Lim Shanhui Gillian
Dec 5, 2009·Clinical Neuropharmacology·Lorena TschoppFederico Micheli
Feb 21, 2009·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Kazuo WashidaRyosuke Takahashi
Apr 10, 2014·Current Pain and Headache Reports·Amelie Govare, Elizabeth Leroux
Jul 5, 2012·European Addiction Research·Susana Jiménez-MurciaJosé Manuel Menchón
Jun 10, 2011·Expert Review of Neurotherapeutics·Daniela Calandrella, Angelo Antonini
Apr 5, 2011·Neuropharmacology·Christopher M Olsen
Jan 13, 2009·Addiction·Malcolm Lader
Oct 18, 2016·Drugs -- Real World Outcomes·Samantha A HollingworthMervyn J Eadie
Feb 4, 2010·Parkinsonism & Related Disorders·Roberto MaggioMark J Millan
Dec 21, 2012·Santé mentale au Québec·Dominic NadeauMartine Simard
Apr 15, 2009·Current Opinion in Psychiatry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.